Pazhanivel Mohan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Pazhanivel Mohan has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Jayanthi Venkataraman
Stanley Medical College
7 shared publications- Kuppusamy Senthamizhselvan
Department of Medical Gastroenterology, JIPMER, Puducherry, India
4 shared publications - Abdoul Hamide
Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
3 shared publications Abdoul Hamide
Department of Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
2 shared publications- Bhawana Ashok Badhe
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India
2 shared publications - Bheemanathi Hanuman Srinivas
Department of Pathology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 13 March 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (3) , 408-414
Comparison of first-attempt endoscope insertion success between LMA® Gastro™ and low-flow nasal cannula during upper gastrointestinal endoscopy: A prospective randomised controlled trial
Background and Aims: Upper gastrointestinal (GI) endoscopic procedures under total intravenous anaesthesia (TIVA) pose risks of sedation-related complications. This study compared the first-attempt endoscope insertion success between the Laryngeal Mask Airway ® (LMA) Gastro™ and low-flow nasal cannula during upper GI endoscopy under TIVA. Methods: This prospective randomised controlled study involved 140 adult patients scheduled for upper GI endoscopy under TIVA. The participants were randomly assigned into two groups: Group L (LMA ® Gastro™) and Group C (low-flow nasal cannula). In Group L, LMA ® Gastro™ was inserted, and in Group C, oxygen was supplemented using a low-flow nasal cannula at 4 litres/min. The primary outcome was first-attempt success of endoscope insertion. Secondary outcomes included endoscope insertion time, endoscopist and anaesthesiologist satisfaction scores, and intra- and postoperative complications. Data were analysed using statistical package for social sciences (SPSS) 19.0, and P < 0.05 was considered statistically significant. Results: The first-attempt success rate for endoscope insertion was comparable between the groups (Group L: 92.6% vs. Group C: 95.7%, P = 0.44). However, the endoscopy insertion time was significantly prolonged in Group L (Median [interquartile range] (seconds): 30 [22-41] vs. 17.5 [13-22], P < 0.001). Anaesthesiologist satisfaction was comparable between the groups, but endoscopists were more satisfied with Group C ( P < 0.001). Group L had significantly fewer intraoperative respiratory adverse events compared with Group C; however, a higher incidence of postoperative sore throat was observed in Group L (20.5%). Conclusion: The first-attempt endoscope insertion success rate was comparable between the LMA ® Gastro™ and nasal cannula groups in patients undergoing upper GI endoscopy under TIVA.
- 13 March 2026
- Published by Wolters Kluwer Health in Indian Journal of Anaesthesia
- Vol. 70 (3) , 408-414
Top Cited PapersOpen AccessComparison of first-attempt endoscope insertion success between LMA® Gastro™ and low-flow nasal cannula during upper gastrointestinal endoscopy: A prospective randomised controlled trial
Background and Aims: Upper gastrointestinal (GI) endoscopic procedures under total intravenous anaesthesia (TIVA) pose risks of sedation-related complications. This study compared the first-attempt endoscope insertion success between the Laryngeal Mask Airway ® (LMA) Gastro™ and low-flow nasal cannula during upper GI endoscopy under TIVA. Methods: This prospective randomised controlled study involved 140 adult patients scheduled for upper GI endoscopy under TIVA. The participants were randomly assigned into two groups: Group L (LMA ® Gastro™) and Group C (low-flow nasal cannula). In Group L, LMA ® Gastro™ was inserted, and in Group C, oxygen was supplemented using a low-flow nasal cannula at 4 litres/min. The primary outcome was first-attempt success of endoscope insertion. Secondary outcomes included endoscope insertion time, endoscopist and anaesthesiologist satisfaction scores, and intra- and postoperative complications. Data were analysed using statistical package for social sciences (SPSS) 19.0, and P < 0.05 was considered statistically significant. Results: The first-attempt success rate for endoscope insertion was comparable between the groups (Group L: 92.6% vs. Group C: 95.7%, P = 0.44). However, the endoscopy insertion time was significantly prolonged in Group L (Median [interquartile range] (seconds): 30 [22-41] vs. 17.5 [13-22], P < 0.001). Anaesthesiologist satisfaction was comparable between the groups, but endoscopists were more satisfied with Group C ( P < 0.001). Group L had significantly fewer intraoperative respiratory adverse events compared with Group C; however, a higher incidence of postoperative sore throat was observed in Group L (20.5%). Conclusion: The first-attempt endoscope insertion success rate was comparable between the LMA ® Gastro™ and nasal cannula groups in patients undergoing upper GI endoscopy under TIVA.
- Open Access
- 25 April 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (5) , e01683
Isolated Metachronous Intraluminal Colonic Metastasis in Carcinoma Gall Bladder: The Path Less Trodden
Gallbladder cancer (GBC) is characterized by late presentation, early systemic spread, and poor long-term survival. A 65-year-old woman presented with isolated intraluminal colonic metastasis 46 months after radical surgery for GBC. The patient also underwent subtotal cholecystectomy 12 years before the diagnosis of GBC. In view of gastrointestinal bleeding, the patient underwent laparoscopic transverse colectomy with colocolic anastomosis. Metachronous isolated intraluminal colonic metastasis is being reported for the first time in English literature. The possible routes of colonic metastasis and its optimum management in the metachronous setting are discussed in this report.
- 25 April 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (5) , e01683
Open AccessIsolated Metachronous Intraluminal Colonic Metastasis in Carcinoma Gall Bladder: The Path Less Trodden
Gallbladder cancer (GBC) is characterized by late presentation, early systemic spread, and poor long-term survival. A 65-year-old woman presented with isolated intraluminal colonic metastasis 46 months after radical surgery for GBC. The patient also underwent subtotal cholecystectomy 12 years before the diagnosis of GBC. In view of gastrointestinal bleeding, the patient underwent laparoscopic transverse colectomy with colocolic anastomosis. Metachronous isolated intraluminal colonic metastasis is being reported for the first time in English literature. The possible routes of colonic metastasis and its optimum management in the metachronous setting are discussed in this report.
- Open Access
- 15 March 2024
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 27 (1) , 1-11
Congenital bilio-bronchial fistula in an adult: a review of literature and video demonstration of laparoscopic fistula tract excision
Chandrasekar Murugesan, Muniza Bai, Biju Pottakkat, Dharm Prakash Dwivedi, Hemachandren Munuswamy, Pazhanivel Mohan. Journal of Minimally Invasive Surgery 2024;27:1-11. https://doi.org/10.7602/jmis.2024.27.1.1
- 15 March 2024
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 27 (1) , 1-11
Open AccessCongenital bilio-bronchial fistula in an adult: a review of literature and video demonstration of laparoscopic fistula tract excision
Chandrasekar Murugesan, Muniza Bai, Biju Pottakkat, Dharm Prakash Dwivedi, Hemachandren Munuswamy, Pazhanivel Mohan. Journal of Minimally Invasive Surgery 2024;27:1-11. https://doi.org/10.7602/jmis.2024.27.1.1
- Open Access
- 1 February 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (2) , e01283
Skull Base Metastasis and Krukenberg Tumor in a Pregnant Woman: An Unusual Presentation of Metastatic Gastric Cancer
Gastric cancer is an infrequent cause of vomiting during pregnancy. It is often diagnosed at an advanced stage due to late presentation by patients, mistaking it for gestational symptoms. We report a 24-year-old pregnant woman with gastric cancer with skull base metastasis and Krukenberg tumor on initial diagnosis. She underwent medical termination of pregnancy and best supportive care before dying of her illness.
- 1 February 2024
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 11 (2) , e01283
Open AccessSkull Base Metastasis and Krukenberg Tumor in a Pregnant Woman: An Unusual Presentation of Metastatic Gastric Cancer
Gastric cancer is an infrequent cause of vomiting during pregnancy. It is often diagnosed at an advanced stage due to late presentation by patients, mistaking it for gestational symptoms. We report a 24-year-old pregnant woman with gastric cancer with skull base metastasis and Krukenberg tumor on initial diagnosis. She underwent medical termination of pregnancy and best supportive care before dying of her illness.
- Open Access
- 25 December 2023
- Published by Xia & He Publishing in Journal of Translational Gastroenterology
- Vol. 1 (2) , 74-86
Obesity and Metabolic Dysfunction-associated Fatty Liver Disease: Understanding the Intricate Link
Obesity is a complex disease resulting from excessive adipose tissue in the body, leading to various metabolic, mechanical, and psychological complications. The prevalence of obesity has increased exponentially in the past few decades to reach an epidemic proportion. Obesity can predispose to or aggravate the fatty liver. Metabolic dysfunction-associated fatty liver disease (MAFLD) represents fatty liver in individuals who are either overweight/obese, or have type 2 diabetes, or have normal weight with at least two metabolic risk factors. MAFLD pathogenesis is multifactorial and involves an interplay of genetics, lifestyle-related factors, gut dysbiosis, lipotoxicity, and oxidative stress. Besides hepatic complications, MAFLD also has systemic implications in the form of increased risk for various metabolic diseases, cardiovascular diseases, malignancies, and infectious diseases. If left untreated, MAFLD can progress to liver cirrhosis and end-stage liver disease. Many noninvasive strategies like serum-based markers and imaging help diagnose MAFLD at an early stage. Timely detection and appropriate intervention are crucial for preventing its progression to advanced liver disease and hepatocellular carcinoma. Though lifestyle modification remains the main pillar of management, with advances in the treatment of obesity, newer agents are being tried for patients with MAFLD. The current therapeutic strategies are limited, and future research is needed to identify the subset of patients with MAFLD who are at a higher risk of hepatic and systemic complications and to develop more effective and personalized therapies.
- 25 December 2023
- Published by Xia & He Publishing in Journal of Translational Gastroenterology
- Vol. 1 (2) , 74-86
Open AccessObesity and Metabolic Dysfunction-associated Fatty Liver Disease: Understanding the Intricate Link
Obesity is a complex disease resulting from excessive adipose tissue in the body, leading to various metabolic, mechanical, and psychological complications. The prevalence of obesity has increased exponentially in the past few decades to reach an epidemic proportion. Obesity can predispose to or aggravate the fatty liver. Metabolic dysfunction-associated fatty liver disease (MAFLD) represents fatty liver in individuals who are either overweight/obese, or have type 2 diabetes, or have normal weight with at least two metabolic risk factors. MAFLD pathogenesis is multifactorial and involves an interplay of genetics, lifestyle-related factors, gut dysbiosis, lipotoxicity, and oxidative stress. Besides hepatic complications, MAFLD also has systemic implications in the form of increased risk for various metabolic diseases, cardiovascular diseases, malignancies, and infectious diseases. If left untreated, MAFLD can progress to liver cirrhosis and end-stage liver disease. Many noninvasive strategies like serum-based markers and imaging help diagnose MAFLD at an early stage. Timely detection and appropriate intervention are crucial for preventing its progression to advanced liver disease and hepatocellular carcinoma. Though lifestyle modification remains the main pillar of management, with advances in the treatment of obesity, newer agents are being tried for patients with MAFLD. The current therapeutic strategies are limited, and future research is needed to identify the subset of patients with MAFLD who are at a higher risk of hepatic and systemic complications and to develop more effective and personalized therapies.
- 22 September 2023
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 118 (3) , 616-625
Racecadotril Versus Loperamide in Acute Radiation Enteritis: A Randomized, Double-Masked, Phase 3, Noninferiority Trial
- 22 September 2023
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 118 (3) , 616-625
Racecadotril Versus Loperamide in Acute Radiation Enteritis: A Randomized, Double-Masked, Phase 3, Noninferiority Trial
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 10 (4) , e01031
An Uncommon Cause of Chronic Nonhealing Perianal Ulcer
Chronic or persistent, nonhealing perianal ulcers could be due to an infection, inflammation, or a neoplasm. Perianal ulcer as the initial presentation of tuberculosis is rare. Tuberculosis cutis orificialis is a rare ulcerative form of cutaneous tuberculosis that affects the oral cavity, anal canal, or perianal region. A high index of suspicion for tuberculosis as the cause of persistent perianal ulcer is required for early diagnosis and treatment.
- 1 April 2023
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 10 (4) , e01031
Open AccessAn Uncommon Cause of Chronic Nonhealing Perianal Ulcer
Chronic or persistent, nonhealing perianal ulcers could be due to an infection, inflammation, or a neoplasm. Perianal ulcer as the initial presentation of tuberculosis is rare. Tuberculosis cutis orificialis is a rare ulcerative form of cutaneous tuberculosis that affects the oral cavity, anal canal, or perianal region. A high index of suspicion for tuberculosis as the cause of persistent perianal ulcer is required for early diagnosis and treatment.
- 1 June 2022
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 41 (3) , 247-257
Effectiveness of low-volume split-dose versus same-day morning polyethylene glycol regimen for adequacy of bowel preparation in patients undergoing colonoscopy: A single-blinded randomized controlled trial
Background Successful completion of colonoscopy depends largely on the quality of bowel preparation. Polyethylene glycol (PEG) is a commonly used preparation for colonoscopy. The timing of bowel preparation has evolved from previous day evening to the currently recommended split-dose regimen. It was observed that consumption of entire or a portion of PEG on the previous day can interfere with work and sleep. Hence, we designed this single-blinded randomized controlled trial (RCT) to evaluate the efficacy, tolerability, and acceptability of the same-day PEG as compared with lowvolume split-dose PEG in patients undergoing late morning colonoscopy. Methods A total of 384 patients were randomized to same-day (SD group; n = 192) and split-dose (SPL group; n = 192) bowel preparation. The patients in both the groups received bisacodyl 10 mg at bedtime on the day prior to colonoscopy. The patients in the SD group took 2 L of PEG between 5:00 AM and 7:00 AM on the day of colonoscopy. The SPL group took 1 L of PEG between 6:00 PM and 7:00 PM on the preceding day and another liter between 6:00 AM and 7:00 AM on the day of colonoscopy. The adequacy of bowel preparation was assessed using the Boston Bowel Preparation Scale (BBPS). Tolerability was scored by recording symptoms such as nausea, vomiting, bloating, and abdominal pain. Acceptability was based on the overall satisfaction, willingness to repeat the same preparation, and interference with sleep on the preceding night. Results The median (interquartile range, [IQR]) BBPS in the SD group was 8 (6–9) while that in the SPL group was 6 (5–8) and this difference was statistically significant (p < 0.001). Similarly, a significantly higher proportion of patients in the SD group (86%) achieved adequate bowel preparation (BBPS score ≥ 6) when compared to those in the SPL group (73.4%) (p = 0.002). Tolerability as assessed by nausea, vomiting, bloating, and abdominal pain was similar in both the groups. There was also no significant difference with respect to overall satisfaction of taking bowel preparation (p = 0.33) or willingness to repeat the same regimen (p = 0.37) between the two groups. Patients in the SPL group had more interference with sleep on the preceding night (54% vs. 14.5%, p < 0.001). Conclusion Same-day morning PEG regimen can be considered an effective, well-tolerated, and acceptable bowel preparation for colonoscopy.
- 1 June 2022
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 41 (3) , 247-257
Effectiveness of low-volume split-dose versus same-day morning polyethylene glycol regimen for adequacy of bowel preparation in patients undergoing colonoscopy: A single-blinded randomized controlled trial
Background Successful completion of colonoscopy depends largely on the quality of bowel preparation. Polyethylene glycol (PEG) is a commonly used preparation for colonoscopy. The timing of bowel preparation has evolved from previous day evening to the currently recommended split-dose regimen. It was observed that consumption of entire or a portion of PEG on the previous day can interfere with work and sleep. Hence, we designed this single-blinded randomized controlled trial (RCT) to evaluate the efficacy, tolerability, and acceptability of the same-day PEG as compared with lowvolume split-dose PEG in patients undergoing late morning colonoscopy. Methods A total of 384 patients were randomized to same-day (SD group; n = 192) and split-dose (SPL group; n = 192) bowel preparation. The patients in both the groups received bisacodyl 10 mg at bedtime on the day prior to colonoscopy. The patients in the SD group took 2 L of PEG between 5:00 AM and 7:00 AM on the day of colonoscopy. The SPL group took 1 L of PEG between 6:00 PM and 7:00 PM on the preceding day and another liter between 6:00 AM and 7:00 AM on the day of colonoscopy. The adequacy of bowel preparation was assessed using the Boston Bowel Preparation Scale (BBPS). Tolerability was scored by recording symptoms such as nausea, vomiting, bloating, and abdominal pain. Acceptability was based on the overall satisfaction, willingness to repeat the same preparation, and interference with sleep on the preceding night. Results The median (interquartile range, [IQR]) BBPS in the SD group was 8 (6–9) while that in the SPL group was 6 (5–8) and this difference was statistically significant (p < 0.001). Similarly, a significantly higher proportion of patients in the SD group (86%) achieved adequate bowel preparation (BBPS score ≥ 6) when compared to those in the SPL group (73.4%) (p = 0.002). Tolerability as assessed by nausea, vomiting, bloating, and abdominal pain was similar in both the groups. There was also no significant difference with respect to overall satisfaction of taking bowel preparation (p = 0.33) or willingness to repeat the same regimen (p = 0.37) between the two groups. Patients in the SPL group had more interference with sleep on the preceding night (54% vs. 14.5%, p < 0.001). Conclusion Same-day morning PEG regimen can be considered an effective, well-tolerated, and acceptable bowel preparation for colonoscopy.
- Open Access
- 11 April 2022
- Published by Medknow in Journal of Postgraduate Medicine
- Vol. 68 (2) , 98-99
Esophageal squamous cell cancer in Plummer-Vinson syndrome: Is lichen planus a missing link?
This retrospective study analyzed the occurrence of esophageal squamous cell cancer (ESCC) in a cohort of patients with Plummer-Vinson syndrome (PVS) and mucosal lichen planus (LP). ESCC occurred in 6.2% cases of PVS, more than half of whom had associated oral LP. Mucosal LP and PVS together may increase the predisposition to ESCC.
- 11 April 2022
- Published by Medknow in Journal of Postgraduate Medicine
- Vol. 68 (2) , 98-99
Open AccessEsophageal squamous cell cancer in Plummer-Vinson syndrome: Is lichen planus a missing link?
This retrospective study analyzed the occurrence of esophageal squamous cell cancer (ESCC) in a cohort of patients with Plummer-Vinson syndrome (PVS) and mucosal lichen planus (LP). ESCC occurred in 6.2% cases of PVS, more than half of whom had associated oral LP. Mucosal LP and PVS together may increase the predisposition to ESCC.
- Open Access
- 1 August 2021
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 8 (8) , e00652
De Novo Crohn's Disease Triggered After COVID-19: Is COVID-19 More Than an Infectious Disease?
Coronavirus disease 2019 (COVID-19)-associated immune dysregulation is believed to trigger the onset of various autoimmune diseases. These occur either during active COVID-19 or soon after recovery. We report ileocolonic Crohn's disease in a 35-year-old woman after her recovery from a milder form of COVID-19. She achieved remission of her symptoms with oral corticosteroids and sulfasalazine.
- 1 August 2021
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 8 (8) , e00652
Open AccessDe Novo Crohn's Disease Triggered After COVID-19: Is COVID-19 More Than an Infectious Disease?
Coronavirus disease 2019 (COVID-19)-associated immune dysregulation is believed to trigger the onset of various autoimmune diseases. These occur either during active COVID-19 or soon after recovery. We report ileocolonic Crohn's disease in a 35-year-old woman after her recovery from a milder form of COVID-19. She achieved remission of her symptoms with oral corticosteroids and sulfasalazine.